Sakar Healthcare Limited

Web: sakarhealthcare.com NSE: SAKAR SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1006 1(0%)

Near 52W High of 999

Volume

1L as on 23, Jun

Open

306

High

306

Low

289

1,007

VWAP

819

52 Week High

999

52 Week Low

321

Viand Research Rating

Quality Score

66/100

Growth Score

90/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,237

No. of Shares

2.22

P/E

P/B

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

ROCE

Profit Growth

Listing Date

11-Apr-19

Promoter Holding

52.52%

FII Holding

12.13%

DII Holding

11.37%

Price Chart

Price Performance

1 Week1%

1 Month7%

3 Months61%

6 Months51%

1 Year51%

YTD51%

Moving Average

5 Day SMA806

10 Day SMA817

20 Day SMA809

30 Day SMA779

50 Day SMA710

61 Day SMA676

80 Day SMA314

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	857	826	842	859
Resistance 2	842	824	832	844
Resistance 1	831	821	826	833
Pivot Point	816	819	816	818
Support 1	805	816	806	807
Support 2	790	814	800	792
Support 3	779	812	790	781

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(-0.31) 52.52%	(0.01) 52.86%	(0.01) 52.86%	(0.01) 52.86%	(-0.71) 52.86%	(0.01) 53.58%	(0.41) 53.58%	(0.01) 53.15%	(0.01) 53.15%	(0.01) 53.15%	(-1.01) 53.15%	(-6.61) 54.15%	(0.01) 60.72%	(-1.41) 60.72%	(0.01) 62.10%	(-5.41) 62.10%	(0.01) 67.54%	(0.01) 67.54%	(0.01) 67.54%	(0.01) 67.54%
FIIs	(-0.81) 12.13%	(-0.11) 12.94%	(-0.31) 13.05%	(-0.11) 13.31%	(-0.21) 13.41%	(0.01) 13.61%	(0.21) 13.58%	(-0.11) 13.42%	(0.01) 13.52%	(-0.21) 13.52%	(-0.31) 13.76%	(-1.71) 14.03%	(0.01) 15.74%	(-0.41) 15.74%	(0.01) 16.12%	(16.11) 16.12%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
DIIs	(0.01) 11.37%	(0.01) 11.32%	(-0.11) 11.36%	(0.21) 11.43%	(0.31) 11.25%	(0.11) 10.97%	(0.31) 10.88%	(0.01) 10.62%	(0.01) 10.62%	(0.01) 10.62%	(-0.21) 10.62%	(10.81) 10.82%	(0.01) 0.00%	(-0.31) 0.00%	(-0.21) 0.33%	(-8.21) 0.55%	(0.01) 8.76%	(0.01) 8.76%	(0.01) 8.76%	(0.01) 8.76%
Public	23.98%	22.87%	22.73%	22.41%	22.48%	21.85%	21.96%	22.80%	22.71%	22.71%	22.47%	21.00%	23.54%	23.54%	21.45%	21.24%	23.70%	23.70%	23.70%	23.70%
No. of Shareholders	14,734	9,580	7,069	7,565	8,115	8,608	8,598	7,867	7,313	7,386	7,001	7,299	6,056	6,322	6,210	5,678	6,091	6,702	6,542	6,481

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	73	71	70	58	53	50	43	43	41	43	37	34	39	41	33	30.71	28.53	36.59	29.74	31.64	30.26
Sales Growth % (YoY)	38.4%	41.5%	62%	34.6%	28.2%	16.7%	16.6%	25.5%	5.5%	5.9%	11.2%	11%	36.7%	11.1%	13%	-2.9%	-5.7%	68.8%	11%	21.1%	50.2%
Sales Growth % (QoQ)	2.8%	1.4%	20.7%	9.4%	6%	16.3%	-	4.9%	-4.7%	16.2%	8.8%	-12.8%	-4.9%	24.2%	7.5%	7.6%	-22%	23%	-6%	4.6%	-
Expenses	52	45	52	46	40	35	32	31	30	32	28	25	30	33	25	22.12	20.57	27.48	23.09	24.55	23.77
Operating Profit	21	26	19	11	13	16	12	12	11	11	9	9	9	8	9	8.59	7.96	9.11	6.65	7.09	6.49
OPM %	29	37	26	20	24	31	27	27	26	25	24	27	23	19	26	27.97	27.9	24.9	22.36	22.41	21.45
Other Income	2	0	1	1	0	0	0	0	0	1	0	1	2	2	2	0.6	0.41	0.88	0.27	0.75	0.27
Interest	2	2	2	2	2	4	1	2	1	2	2	2	2	2	2	0.99	0.86	0.68	0.94	0.79	0.49
Depreciation	7	6	6	6	6	5	5	5	5	5	4	4	5	4	4	3.77	3.57	3.19	2.62	1.68	2.18
Profit before tax	15	18	11	5	5	6	5	5	5	5	3	4	4	4	5	4.43	3.94	6.12	3.36	5.37	4.09
Tax %	29	39	6	15	13	8	17	6	49	35	31	13	28	-1	13	56.21	26.9	-46.24	96.43	54.19	10.51
Net Profit	10	11	10	5	5	6	5	5	2	3	2	4	3	4	4	1.94	2.88	8.95	0.11	2.46	3.65
Net Profit Growth % (QoQ)	-9.1%	10%	100%	-	-16.7%	20%	-	150%	-33.3%	50%	-50%	33.3%	-25%	-	106.2%	-32.6%	-67.8%	8036.4%	-95.5%	-32.6%	-
Net Profit Growth % (YoY)	100%	83.3%	100%	-	150%	100%	150%	25%	-33.3%	-25%	-50%	106.2%	4.2%	-55.3%	3536.4%	-21.1%	-21.1%	-	-	-	-
TTM Net Profit	36	31	26	21	21	18	15	12	11	12	13	15	12.94	12.82	17.77	13.88	14.4	15.17	6.22	6.11	0
EPS in Rs	4.62	4.95	4.61	2.04	2.1	2.62	2.06	2.21	1.11	1.43	0.95	1.7	1.49	2.06	2.15	1.04	1.68	5.23	0.06	1.44	2.13

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	252	178	153	133	128	95	83	68	53	44	41	35	30	22
Sales Growth %	41.8%	15.8%	15%	4%	35.3%	14.2%	-	28.6%	20.1%	7.1%	17.7%	18%	35.5%	35.3%
Expenses	183	128	115	100	99	72	63	51	40	34	33	27	22	14
Operating Profit	69	50	38	33	29	23	20	17	13	10	8	8	8	8
OPM %	27	28	25	25	23	24	24	25	24	23	20	22	26	34
Other Income	2	1	3	5	2	1	2	1	0	1	0	0	0	0
Interest	8	9	8	6	3	2	2	2	3	3	3	3	4	4
Depreciation	24	21	18	15	10	8	7	6	4	3	3	2	2	2
Profit before tax	40	22	16	17	19	13	12	9	6	5	3	2	2	2
Tax %	23	19	27	24	20	19	21	28	38	30	22	24	13	19
Net Profit	30	18	12	13	15	11	10	7	4	3	2	2	2	1
Net Profit Growth %	66.7%	50%	-7.7%	-13.3%	36.4%	10%	42.9%	75%	33.3%	50%	-	-	100%	-
EPS in Rs	13.7	7.97	5.37	6.7	8.9	6.84	6.43	4.47	3.12	3.08	2.78	2.3	2.19	1.81
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	49	34	24	33	36	15	19	16	5	2	9	4	9	7
Cash from Investing Activity	-28	-31	-52	-74	-90	-47	-22	-25	-8	-14	-4	-1	-3	-3
Cash from Financing Activity	-21	-3	27	41	55	32	3	9	-13	13	-6	-3	-6	-7
Net Cash Flow	0	0	0	0	0	0	0	0	-16	0	-1	1	0	-4

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	22	22	22	22	22	19	17	16	15	15	12	11	8	8	8	8
Reserves	302	281	264	248	241	154	110	83	66	57	39	25	11	7	6	4
Borrowings	55	72	86	74	79	119	93	43	17	11	11	24	22	25	24	27
Other Liabilities	101	73	43	61	47	44	47	37	17	15	18	11	10	11	14	11
Total Liabilities	481	449	415	404	389	336	268	178	115	97	81	71	51	50	52	50
Fixed Assets	326	325	309	317	314	267	205	69	66	64	53	49	37	36	38	37
CWIP	4	17	17	1	0	6	1	49	13	9	0	0	0	0	0	0
Investments	0	0	0	0	0	3	7	0	0	0	0	0	0	0	0	0
Other Assets	151	107	90	87	74	60	55	60	36	25	28	22	14	14	14	13
Total Assets	481	449	415	404	389	336	268	178	115	97	81	71	51	50	52	50

Delivery

Delivery Data: SAKAR

#	Date	786 30% 1024	Value (Cr)	Q/T 17	Del 40	Del 14
1	4-Sep	1014	9	15	54	5
2	3-Sep	1007	17	17	46	8
3	2-Sep	986	38	20	32	12
4	1-Sep	966	114	20	23	26
5	31-Aug	863	8	16	55	4
6	28-Aug	876	7	16	57	4
7	27-Aug	893	7	15	53	4
8	26-Aug	901	5	16	59	3
9	25-Aug	885	7	13	46	3
10	24-Aug	900	5	15	52	3
11	21-Aug	913	7	15	55	4
12	20-Aug	885	3	14	51	2
13	19-Aug	871	6	14	55	3
14	18-Aug	894	5	16	56	3
15	17-Aug	905	10	13	50	5
16	14-Aug	876	24	17	45	11
17	13-Aug	918	9	15	52	5
18	12-Aug	936	7	11	47	3
19	11-Aug	954	27	14	40	11
20	10-Aug	905	15	14	44	6
21	7-Aug	925	8	13	45	3
22	6-Aug	920	12	14	45	5
23	5-Aug	891	10	11	47	5
24	4-Aug	916	6	11	53	3
25	3-Aug	922	17	16	47	8
26	31-Jul	885	18	16	48	9
27	30-Jul	844	5	16	48	2
28	29-Jul	850	7	15	46	3
29	28-Jul	847	13	14	34	4
30	27-Jul	830	9	13	44	4
31	24-Jul	802	45	15	21	9
32	23-Jul	828	9	13	42	4
33	22-Jul	837	11	13	53	6
34	21-Jul	879	6	14	54	3
35	20-Jul	899	7	13	40	3
36	17-Jul	878	11	14	45	5
37	16-Jul	897	19	16	36	7
38	15-Jul	917	14	15	44	6
39	14-Jul	904	72	23	28	20
40	13-Jul	864	25	22	45	11
41	10-Jul	824	7	20	52	4
42	9-Jul	800	7	17	47	3
43	8-Jul	800	9	21	53	5
44	7-Jul	823	6	14	45	3
45	6-Jul	835	14	15	40	6
46	3-Jul	849	26	16	35	9
47	2-Jul	834	9	18	51	5
48	1-Jul	812	9	23	57	5
49	30-Jun	838	7	18	58	4
50	29-Jun	832	14	21	52	7

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	2,238c	1c	0.06
03-Sep	2,236c	293c	15.06
01-Sep	1,943c	9c	0.48
31-Aug	1,953c	45c	2.24
27-Aug	1,998c	16c	0.80
26-Aug	2,014c	44c	2.25
25-Aug	1,969c	36c	1.77
24-Aug	2,005c	23c	1.11
21-Aug	2,027c	78c	4.02
19-Aug	1,949c	51c	2.57
18-Aug	2,000c	25c	1.21
17-Aug	2,025c	71c	3.64
14-Aug	1,954c	86c	4.23
13-Aug	2,040c	52c	2.47
12-Aug	2,092c	25c	1.20
11-Aug	2,117c	84c	4.14
10-Aug	2,033c	20c	0.95
06-Aug	2,052c	88c	4.47
05-Aug	1,964c	74c	3.62
04-Aug	2,038c	52c	2.60
31-Jul	1,987c	101c	5.33
30-Jul	1,886c	30c	1.56
29-Jul	1,916c	27c	1.42
28-Jul	1,889c	44c	2.40
27-Jul	1,845c	0	0

Stock Checklist

Price is above from 52 week high low average: 101%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

NseIndia | Trendlyne | Screener | TradingView